Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-007-9620-xPMID 17549626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

  2006cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid

  2006cited by this paper
• Promoter Hypermethylation as an Independent Prognostic Factor for Relapse in Patients with Prostate Cancer Following Radical Prostatectomy

  2005cited by this paper
• Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.

  2005cited by this paper
• Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.

  2005cited by this paper
• MT1G Hypermethylation Is Associated with Higher Tumor Stage in Prostate Cancer

  2005cited by this paper
• Frequent 14-3-3 σ Promoter Methylation in Benign and Malignant Prostate Lesions

  2005cited by this paper
• Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung

  2004cited by this paper
• Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer

  2004cited by this paper
• Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.

  2004cited by this paper
• A Quantitative Promoter Methylation Profile of Prostate Cancer

  2004cited by this paper
• Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Methylation Profiling of Benign and Malignant Breast Lesions and Its Application to Cytopathology

  2003cited by this paper
• DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma

  2003cited by this paper
• Biallelic inactivation of the RIZ1 gene in human gastric cancer

  2003cited by this paper
• Detection of gene promoter hypermethylation in fine needle washings from breast lesions.

  2003influential reference
• DNA methylation in serum of breast cancer patients: an independent prognostic marker.

  2003cited by this paper
• Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype.

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Improved Breast Cytology Results with Near Patient FNA Diagnosis

  2002cited by this paper
• Behavioural genetics: Worms gang up on bacteria

  2002cited by this paper
• Quantitative assessment of promoter hypermethylation during breast cancer development.

  2002influential reference
• Emerging molecular markers of cancer

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Behavioural genetics: Worms gang up on bacteria

  2002cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers

  2001cited by this paper
• Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.

  2001cited by this paper
• DNA methylation, chromatin inheritance, and cancer

  2001cited by this paper
• Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.

  2001cited by this paper
• Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

  2001cited by this paper
• Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.

  2001cited by this paper
• Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.

  2001cited by this paper
• Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

  2001cited by this paper
• High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.

  2000cited by this paper
• MethyLight: a high-throughput assay to measure DNA methylation.

  2000cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.

  2000cited by this paper
• Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

  2000cited by this paper
• Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.

  2000cited by this paper
• A modified and improved method for bisulphite based cytosine methylation analysis.

  1996cited by this paper
• E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

  1995cited by this paper
• Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

  1994cited by this paper
• Diagnostic Histopathology of the Breast

  1988cited by this paper

• A Review on the Impact of Aberrant Methylation in Breast Cancer: Diagnostic, Prognostic, and Therapeutic Approaches

  2024cites this paper
• Tumor Microenvironment and Epigenetic Implications in Breast Cancer Progression.

  2024cites this paper
• Molecular evaluation of a multiplex methylation panel for epigenetic analysis of FNAB samples from Greek patients with suspicious breast lesions.

  2020influential citation
• Association of Methylation of RASSF1A between Breast Cancer and Benign Breast Lesions: A Meta-Analysis

  2020cites this paper
• DNA methylation patterns of RAR‐β2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions

  2020cites this paper
• Promoter Methylation Status of the Retinoic Acid Receptor-Beta 2 Gene in Breast Cancer Patients: A Case Control Study and Systematic Review

  2019cites this paper
• Association between methylation of RASSF1A and breast cancer: a meta-analysis

  2019cites this paper
• Clinical Significance of Fine Needle Aspiration in Managing Patients with Breast Lesions

  2018cites this paper
• A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA

  2018cites this paper
• A PRISMA-compliant meta-analysis

  2018cites this paper
• Evaluation of TAGLN as a diagnostic marker in breast cancer

  2018cites this paper
• Morphological and Molecular Approaches to Breast Cancer Risk Assessment

  2018cites this paper
• Cancer epigenetics: Moving forward

  2018cites this paper
• The Epigenomic Revolution in Breast Cancer: From Single-Gene to Genome-Wide Next-Generation Approaches.

  2017cites this paper
• Quantitative assessment of the association between APC promoter methylation and breast cancer

  2016cites this paper
• Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis

  2016influential citation
• Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies

  2016cites this paper
• Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer

  2016cites this paper
• Methylome of breast cancer molecular subtypes: diagnosis and prognosis biomarkers

  2016cites this paper
• Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer

  2016cites this paper
• The application of RASSF 1 A promoter methylation as a biomarker in breast cancer : a comprehensive literature review

  2016cites this paper
• Methods for genome-wide DNA methylation analysis in human cancer.

  2016cites this paper
• Molecular Analysis of Breast Cancer in Cytology Samples

  2016cites this paper
• MULTIPLE SOURCES OF PAH EXPOSURE, DNA METHYLATION AND BREAST CANCER

  2015cites this paper
• Diagnostic and prognostic epigenetic biomarkers in cancer.

  2015cites this paper
• Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors

  2015cites this paper
• Pregnancy associated breast cancer (PABC): aspects in diagnosis.

  2015cites this paper
• Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies

  2015cites this paper
• Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential

  2015cites this paper
• Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis

  2015cites this paper
• BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer

  2014cites this paper
• Alterações epigenéticas e do número de cópias do gene SFN em carcinomas mamários

  2014cites this paper
• Pan-cancer patterns of DNA methylation

  2014cites this paper
• Modern methods in breast cancer diagnostics

  2014cites this paper
• Methylation status and protein expression of RASSF1A in breast cancer patients

  2013cites this paper
• Breast Cancer: Pathology, Cytology, and Core Needle Biopsy Methods for Diagnosis

  2013cites this paper
• A Gene Hypermethylation in Tissue and Serum Together with Tissue Protein Expression in Breast Cancer Patients

  2012cites this paper
• Diagnostic value of fine-needle aspiration biopsy for breast mass: a systematic review and meta-analysis

  2012cites this paper
• DNA methylation based biomarkers: practical considerations and applications.

  2012cites this paper
• Core needle biopsy versus fine needle aspiration biopsy in breast—A historical perspective and opportunities in the modern era

  2011cites this paper
• Expression of 14-3-3 σ protein in normal and neoplastic canine mammary gland.

  2011cites this paper
• Hypermethylation of CCND2 May Reflect a Smoking-Induced Precancerous Change in the Lung

  2011cites this paper
• Improving early breast cancer detection: focus on methylation.

  2011cites this paper
• Risk factors and novel biomarkers in breast cancer

  2011cites this paper
• Hypermethylation of the GSTP1 promoter region in breast cancer is associated with prognostic clinicopathological parameters.

  2010cites this paper
• Methylation markers for early breast cancer detection

  2010cites this paper
• Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.

  2010cites this paper
• The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

  2010cites this paper
• Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

  2010cites this paper
• DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study.

  2010cites this paper
• Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients

  2010cites this paper
• INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR

  2009influential citation
• Fine‐needle aspiration for nucleic acid‐ased molecular analyses in breast cancer

  2009cites this paper
• Role of the RARRES1 gene in nasopharyngeal carcinoma.

  2009cites this paper
• Promoter methylation and the detection of breast cancer

  2009cites this paper
• Unraveling Breast Cancer Heterogeneity Through Transcriptomic and Epigenomic Analysis

  2009cites this paper
• Breast cancer screening and biomarkers.

  2009cites this paper
• Raising gestational choline intake alters gene expression in DMBA‐evoked mammary tumors and prolongs survival

  2009cites this paper
• Epigenetic modifications of p16, E-cadherin, RAR beta and DAPK gene promoters in breast cancer

  2008cites this paper
• Role of the wnt signaling pathway and lung cancer.

  2007cites this paper
• Open Access Research Article

  year unknowncites this paper